us stocks traded higher with the dow jones gaining more than 700 points on tuesday here are some big stocks recording losses in today’s session   kalvista pharmaceuticals inc shares dropped 57 to 612 after the company announced it terminated the komplete phase 2 clinical trial for kvd824 for the prevention of attacks in people with hereditary angioedema   faze holdings inc declined 336 to 541 after the company issued a filing showing issuance of up to roughly 592 million shares of common stock the resale of up to roughly 64 million shares of common stock and the resale of roughly 173000 warrants   axt inc fell 178 to 576 after the company cut preliminary q3 revenue guidance below estimates   rallybio corporation dropped 178 to 1221 rallybio recently announced preliminary results from its ongoing phase 1b proofofconcept study of rlyb212 to prevent fetal and neonatal alloimmune thrombocytopenia   sportradar group ag dropped 66 to 818 after b of a securities downgraded the stock from neutral to underperform and lowered its price target from 14 to 8